XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.2
REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)
 6 Months Ended
Jun. 30, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of Changes in Contract Assets and Contract Liabilities
The following table summarized the changes in the contract asset and liability balances for the six months ended June 30, 2023:
Dollars in thousandsTotal
Contract Asset
Contract asset, January 1, 2023
$10,122 
Transferred to trade receivable from contract asset included in beginning of the year contract asset(7,743)
Written off from beginning of the year contract asset due to Boston recall(2,379)
Contract asset, net of transferred to trade receivables on contracts during the period9,639 
Contract asset, June 30, 2023
$9,639 
Contract Liability
Contract liability, January 1, 2023
$16,127 
Recognition of revenue included in beginning of year contract liability$(5,487)
Contract liability, net of revenue recognized on contracts during the period6,172 
Foreign currency translation(15)
Contract liability, June 30, 2023
$16,797 
Schedule of Disaggregation of Revenue
The following table presents revenues disaggregated by the major sources of revenues for the three and six months ended June 30, 2023 and 2022 (dollar amounts in thousands):
Three Months Ended June 30, 2023Three Months Ended June 30, 2022Six Months Ended June 30, 2023Six Months Ended June 30, 2022
Neurosurgery$205,803 $200,295 $398,673 $394,970 
Instruments65,227 57,568 120,493 110,201 
Total Codman Specialty Surgical271,030 257,863 519,166 505,171 
Wound Reconstruction and Care91,118 104,894 192,058 199,524 
Private Label19,119 35,058 50,889 69,758 
Total Tissue Technologies110,237 139,952 242,947 269,282 
Total revenue$381,267 $397,815 $762,113 $774,453